Emory University’s GSK GSK Stock Holding History

Emory University’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-231	Closed	-$15K	–	71
2013 Q4	$15K	Hold	231	–	–	0.01%	26
2013 Q3	$14K	Hold	231	–	–	0.01%	26
2013 Q2	$14K	Buy	+231	New	+$14.7K	0.01%	21

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Emory University's GSK Position: Q1 2014 in Review

Emory University sold out of GSK (GSK) in Q1 2014, closing a stake of 231 shares — an estimated $15K sold.

Emory University first reported a position in GSK in Q2 2013 and held it in 3 quarters. The position peaked at $15K in Q4 2013. 712 funds tracked by Wall St. Rank hold GSK as of Q1 2014.

Emory University reported no remaining GSK position as of Q1 2014 after selling out during the quarter.
Emory University sold 231 GSK shares in Q1 2014, an estimated $15K.
Emory University first reported a position in GSK in Q2 2013 and held it in 3 quarters.
Emory University's GSK position peaked at $15K in Q4 2013.
712 funds tracked by Wall St. Rank held GSK as of Q1 2014.

Based on Emory University's 13F filing for Q1 2014, filed 13 May 2014.